US Patent Issued to Rigel Pharmaceuticals on Aug. 12 for "Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,775, issued on Aug. 12, was assigned to Rigel Pharmaceuticals Inc. (South San Francisco, Calif.).

"Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors" was invented by Jack Maung (South San Francisco, Calif.), Yan Chen (South San Francisco, Calif.), Simon Shaw (South San Francisco, Calif.), David Sweeny (South San Francisco, Calif.) and Esteban Masuda (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitor compounds and compositions comprising such compounds. The compounds may have a structure according to Formula IAlso disclosed are metho...